Amgen to sell cholesterol drug at 60% discount to cash-paying US patients – Reuters

1. Amgen to sell cholesterol drug at 60% discount to cash-paying US patients  Reuters
2. LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS  PR Newswire
3. Evolocumab Reduces Risk of MACE for Patients Without Prior History of Heart Attack, Stroke  Drug Topics
4. GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings  Yahoo Finance
5. AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.  PR Newswire

Continue Reading